AAIM
REGN icon

American Assets Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

American Assets Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87M Hold
3,000
– – 0.11% 123
2026
Q1 		$2.32M Hold
3,000
– – 0.16% 114
2025
Q4 		$2.32M Hold
3,000
– – 0.16% 113
2025
Q3 		$1.69M Hold
3,000
– – 0.12% 119
2025
Q2 		$1.57M Hold
3,000
– – 0.13% 120
2025
Q1 		$1.9M Buy
+3,000
New +$2.06M 0.17% 118

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

American Assets Investment Management's REGN Position: Q2 2026 in Review

American Assets Investment Management held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 3,000 shares worth $1.87M. The position accounts for 0.11% of the portfolio, ranked #123.

American Assets Investment Management first reported a position in REGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.32M in Q1 2026. 1,338 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • American Assets Investment Management held 3,000 shares of Regeneron Pharmaceuticals worth $1.87M as of Q2 2026.
  • American Assets Investment Management left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.11% of American Assets Investment Management's portfolio in Q2 2026, its #123 holding.
  • American Assets Investment Management first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • American Assets Investment Management's Regeneron Pharmaceuticals position peaked at $2.32M in Q1 2026.
  • 1,338 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on American Assets Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.